Digital Art and Artificial Intelligence

Официальное название

Digital Art and Artificial Intelligence : Encouraging the Discovery of the Senses Via the Impressionist Painters for the Well-being of Adults - Qualitative Study

Обзор

The study aims at examining the impact of an immersive and interactive digital application (App) that uses impressionist artworks to promote the mental well-being of both young and older adults. The goal is to study the usability and accessibility of this App, particularly for older adults, who may have sensory impairments and lower digital literacy compared to younger adults. The study is based on the hypothesis that the App, which allows interaction with paintings by Claude Monet and Helen McNicoll, can trigger positive emotions, thereby improving users' well-being. The App uses artificial intelligence to create extensions of the paintings and music based on the sonification of electrophysiological signals captured from plants. The study seeks to answer four research questions: 1. The usage behaviors of young and older adults with the App. 2. The impressions and feedback from users after testing the App. 3. The obstacles and enablers to the App's use. 4. The expectations and needs of users for better use of the App. The study's objectives include analyzing the usage behaviors, impressions, barriers, and needs of both young and older adults. It is a qualitative study based on non-participatory observations and semi-structured interviews with young and older participants who have used the App. The App is based on impressionist artworks, a style known for evoking positive emotions, and aims to promote mental health by harnessing the emotional power of digital art and artificial intelligence.

Вмешательства

• Поведенческое Art application
  First, participants will complete questionnaires that will provide us with their socio-demographic information, their level of knowledge in visual arts and music, as well as their level of eco-anxiety. Second, participants will use the application on a touchscreen tablet: 1. A member of the research team will give a brief explanation of the application. 2. The participant will use the application on the touchscreen tablet. 3. A member of the research team will be present in the room during the

Первичные конечные точки

• Observation grid for behaviors and difficulties encountered [Срок оценки: Day 1, during the use of the app, duration : 30 minutes]
• Impressions and feedback [Срок оценки: Day 1, right after the use of the app, duration : 30 minutes]
• Enablers and barriers [Срок оценки: Day 1, right after the use of the app, duration : 30 minutes]
• Expectations and needs [Срок оценки: Day 1, right after the use of the app, duration : 30 minutes]

Вторичные конечные точки (5)

• Sociodemographics [Срок оценки: Day 1]
• level of visual art knowledge [Срок оценки: Day 1]
• level of music knowledge [Срок оценки: Day 1]
• Ecoanxiety level - Climate change [Срок оценки: Day 1]
• Ecoanxiety level - Environmental issues [Срок оценки: Day 1]

Критерии участия

• For adults of any age:

• Inclusion criteria:

• Concordance of sex and gender.
• No psychiatric or cognitive disorders.
• Ability to understand spoken and written French.
• Provide written consent to participate in the study.
• Exclusion criteria:

• Non-binary.
• Inability to provide informed consent to participate in the study.
• Participation in a concurrent experimental clinical study to avoid interference with our study.
• Inability to understand spoken and written French.
• Having moderate to severe visual or auditory impairment.
• Young adults:

The inclusion criterion is being aged between 18 and 35 years.

• Older adults:

The inclusion criterion is being aged 60 years or older.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Да

Дизайн исследования

Распределение

Нерандомизированное

Модель

Параллельные группы

Маскирование

Открытое

Основная цель

Другое

Центры проведения

Канада · 1 центр

• CRIUGM — Montreal

Идентификаторы

NCT: NCT06609642 · 2025-2244

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗